A novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro and in vivo model systems

Inhibiting the disease progression in KRAS-driven cancers after diagnosis has been a difficult task for clinicians to manage due to lack of effective intervention/preventive therapies. KRAS-driven cancers depend on sustained KRAS-signaling. Although developing inhibitors of KRAS-signaling has proven...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Carcinog
Main Authors: Ganaie, Arsheed A., Siddique, Hifzur R., Sheikh, Ishfaq A., Parray, Aijaz, Wang, Lei, Panyam, Jayanth, Villalta, Peter W., Deng, Yibin, Konety, Badrinath R., Saleem, Mohammad
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7334075/
https://ncbi.nlm.nih.gov/pubmed/32291806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.23200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados